BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 36575448)

  • 1. Quercetin-loaded Liposomes Effectively Induced Apoptosis and Decreased the Epidermal Growth Factor Receptor Expression in Colorectal Cancer Cells: An
    Keshavarz F; Dorfaki M; Bardania H; Khosravani F; Nazari P; Ghalamfarsa G
    Iran J Med Sci; 2023 May; 48(3):321-328. PubMed ID: 37791331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin-biapigenin nanoparticles are effective to penetrate the blood-brain barrier.
    Oliveira AI; Pinho C; Sarmento B; Dias ACP
    Drug Deliv Transl Res; 2022 Jan; 12(1):267-281. PubMed ID: 33709285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regorafenib-induced Myopathy.
    Ochiai S; Ueno T; Igarashi S; Arai A
    Intern Med; 2024 Jan; ():. PubMed ID: 38220194
    [No Abstract]   [Full Text] [Related]  

  • 4. MicroRNA-nanoparticles against cancer: Opportunities and challenges for personalized medicine.
    Martino E; D'Onofrio N; Anastasio C; Abate M; Zappavigna S; Caraglia M; Balestrieri ML
    Mol Ther Nucleic Acids; 2023 Jun; 32():371-384. PubMed ID: 37128277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small interfering RNA for cancer treatment: overcoming hurdles in delivery.
    Charbe NB; Amnerkar ND; Ramesh B; Tambuwala MM; Bakshi HA; Aljabali AAA; Khadse SC; Satheeshkumar R; Satija S; Metha M; Chellappan DK; Shrivastava G; Gupta G; Negi P; Dua K; Zacconi FC
    Acta Pharm Sin B; 2020 Nov; 10(11):2075-2109. PubMed ID: 33304780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of Quercetin or/and siRNA-loaded DDAB-mPEG-PCL hybrid nanoparticles reverse resistance to Regorafenib in colon cancer cells.
    Shahidi S; Rostamizadeh K; Fathi M; Nedaei K; Ramazani A
    BMC Complement Med Ther; 2022 Dec; 22(1):340. PubMed ID: 36575448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis induction by siRNA targeting integrin-β1 and regorafenib/DDAB-mPEG-PCL hybrid nanoparticles in regorafenib-resistant colon cancer cells.
    Zhiani M; Mousavi MA; Rostamizadeh K; Pirizadeh R; Osali A; Mennati A; Motlagh B; Fathi M
    Am J Cancer Res; 2021; 11(4):1170-1184. PubMed ID: 33948352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin mediated down-regulation of α
    Javadi S; Rostamizadeh K; Hejazi J; Parsa M; Fathi M
    Phytother Res; 2018 Feb; 32(2):355-364. PubMed ID: 29168312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulforaphane delivery using mPEG-PCL co-polymer nanoparticles to breast cancer cells.
    Danafar H; Sharafi A; Kheiri Manjili H; Andalib S
    Pharm Dev Technol; 2017 Aug; 22(5):642-651. PubMed ID: 26916923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of siRNA and lycopene encapsulated hybrid lipid nanoparticles for dual silencing of insulin-like growth factor 1 receptor in MCF-7 breast cancer cell line.
    Mennati A; Rostamizadeh K; Manjili HK; Fathi M; Danafar H
    Int J Biol Macromol; 2022 Mar; 200():335-349. PubMed ID: 34999039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Therapeutic Targets of Quercetin, a Plant Flavonol, and Its Role in the Therapy of Various Types of Cancer through the Modulation of Various Cell Signaling Pathways.
    Almatroodi SA; Alsahli MA; Almatroudi A; Verma AK; Aloliqi A; Allemailem KS; Khan AA; Rahmani AH
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33804548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An emerging role for cellular crosstalk in the cancer stem cell niche.
    Oshimori N; Guo Y; Taniguchi S
    J Pathol; 2021 Jul; 254(4):384-394. PubMed ID: 33634866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDAB cationic lipid-mPEG, PCL copolymer hybrid nano-carrier synthesis and application for delivery of siRNA targeting IGF-1R into breast cancer cells.
    Khodaei M; Rostamizadeh K; Taromchi AH; Monirinasab H; Fathi M
    Clin Transl Oncol; 2021 Jun; 23(6):1167-1178. PubMed ID: 33389648
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.